• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Brain Health: A Mysterious Frontier

    State of the Industry: Positive Market Outlook Despite COVID-19 Turmoil

    2021 International Buyers' Guide

    A Health Gap: Disparity in Immunity & Well-Being in 2020

    Glass or Plastic: Understanding the Complete Costs & Sustainability Impact
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    Brown Fat Associated with Reductions in Chronic Disease Risk

    NIH Study Identifies Antibacterial Properties in Taurine

    NSF Begins New Certification Program

    Eriocitrin Shown to Have Metabolic Benefits in Recent Study

    EverGrain Introduces Sustainable Barley Ingredients
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    NIH Study Identifies Antibacterial Properties in Taurine

    Eriocitrin Shown to Have Metabolic Benefits in Recent Study

    EverGrain Introduces Sustainable Barley Ingredients

    AHPA Requests FDA Take a New Approach on Produce Regulation Affecting Herbs

    Preliminary Study Suggests Link Between Omega-3s and Lower COVID-19 Death Rates
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    Brown Fat Associated with Reductions in Chronic Disease Risk

    NIH Study Identifies Antibacterial Properties in Taurine

    NSF Begins New Certification Program

    Eriocitrin Shown to Have Metabolic Benefits in Recent Study

    EverGrain Introduces Sustainable Barley Ingredients
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Brown Fat Associated with Reductions in Chronic Disease Risk

    NIH Study Identifies Antibacterial Properties in Taurine

    Eriocitrin Shown to Have Metabolic Benefits in Recent Study

    EverGrain Introduces Sustainable Barley Ingredients

    Preliminary Study Suggests Link Between Omega-3s and Lower COVID-19 Death Rates
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    Chenland Nutritionals Inc.

    Xsto Solutions

    Verdure Sciences

    Vesta Nutra

    Indena USA, Inc.
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    Nutrition21, LLC

    Chenland Nutritionals Inc.

    KLK OLEO - Davos Life Science

    Xsto Solutions

    Indena USA, Inc.
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Lonza to Acquire Capsugel for $5.5 Billion

    Deal designed to create leading solutions provider in drug development, formulation, delivery technologies and manufacturing.

    Lonza to Acquire Capsugel for $5.5 Billion
    Related CONTENT
    • Lonza’s DRcaps® Capsules Positioned to Help Usher in Next Generation Formulations
    • Lonza Expands Capsule Manufacturing Capacity
    • 2020 Branded Ingredient Directory
    • Capsugel to Showcase Innovative Dosage Forms and Technologies
    • Benexia Opens Lipids Research Center in Europe
    12.15.16
    Lonza Group AG, Basel, Switzerland has entered an agreement to acquire Capsugel from the private equity group KKR for $5.5 billion in cash, including refinancing of existing Capsugel debt of approximately $2 billion. The Boards of Directors of both Lonza and Capsugel have approved the transaction.

    The transaction is expected to close in the second quarter of 2017 and is subject to certain regulatory approvals and other customary closing conditions.

    Lonza said the acquisition is in line with its stated strategy to accelerate growth and deliver value along the healthcare continuum by complementing its existing offerings and by opening up new market opportunities in the pharma and consumer healthcare and nutrition industries. With the acquisition of Capsugel, Lonza will add a trusted brand with a large breadth of technologies and will expand the market reach of its contract development and manufacturing organization (CDMO) and products businesses. It will also support Lonza’s strategic ambition of getting closer to the patient and end consumer.

    The acquisition is designed to create a leading integrated, value-added solutions provider in drug development, formulation, delivery technologies and manufacturing for the global pharma and consumer healthcare industries. The combined business will be positioned to benefit from the dynamics in these industries and to anticipate and address technology trends in order to support the evolving needs of its customers, the companies said. It will provide additional value by offering an integrated portfolio of industry-leading technologies, from active pharmaceutical ingredients (APIs) through excipients to dosage forms and delivery technologies.

    Pfizer had previously sold Capsugel to KKR for nearly $2.38 billion in April 2011. Since that time Capsugel acquired a range of companies, including Bend Research Inc., which specializes in bioavailability enhancement, Xcelience, a CDMO, and Powdersize, a contract manufacturer with expertise in particle-size reduction and control technologies, as well as other new dosage technologies.

    Today, with the addition of Capsugel’s oral dosage delivery technologies, including its leading position in hard capsule technologies, Lonza expects to become the partner of choice for its pharma customers along the entire value chain. The combined technologies and offerings will provide customers innovative solutions in both large and small molecules and strengthen Lonza’s ability to support the pharma industry by bringing new, differentiated medicines to market rapidly and efficiently.

    In addition, the acquisition is expected to strengthen Lonza’s position in consumer healthcare and nutrition as Lonza becomes a fully integrated and innovative service provider of active ingredients, oral dosage forms, development services and delivery technologies. As a result, Lonza will be well positioned to meet the increasing need for optimized consumer health and nutrition through a wide offering of next-generation dosage forms. The combined business will also be able to leverage its bioavailability technology to create a new dietary ingredient-ready offering, as well as capitalize on its formulation expertise to develop new ingredients and to market new combination products.

    The enlarged business would have had combined 2015 revenues of approximately CHF 4.8 billion and adjusted EBITDA of approximately CHF 1.1 billion with an enhanced margin profile. Lonza and Capsugel’s highly synergistic customer base and complementary business models will facilitate seamless integration. The combined business will be able to leverage the strong regulatory track record and global footprint of each company.

    With approximately 3,600 employees and 13 facilities on three continents, Capsugel has a customer-centric, entrepreneurial and collaborative culture that aligns with Lonza’s corporate culture. Both companies focus on quality, operational excellence and delivering on promises.

    “The acquisition of Capsugel meets Lonza’s strategic and financial goals,” said Lonza CEO Richard Ridinger. “It accelerates our healthcare continuum strategy by giving us broader exposure to the fast-growing pharma and consumer healthcare markets. We expect the transaction to be accretive to our core earnings per share in the first full year post closing.”

    He explained further, “This new integrated approach will benefit our customers, who will gain from the simplicity and efficiency of working with one company that can provide world-leading support from APIs to excipients and dosage forms. The combined business will allow us to partner with our customers to help them bring highly differentiated products to market more quickly and efficiently.”

    Guido Driesen, president and CEO of Capsugel, said, “This transaction brings together two leading companies that share a common vision—to deliver real value to customers by accelerating their ability to develop and commercialize innovative pharmaceutical and healthcare products. The combination of our complementary technology platforms will put us in a strong position to benefit from evolving trends in the pharma and consumer healthcare markets.”

    He added, “Both companies enjoy a strong quality and regulatory track record, and we believe that the combination enables us to provide the most complete set of tailored and integrated solutions for our customers. We look forward to bringing together our talented teams to deliver science- and engineering-based solutions to customers for the benefit of the patients and consumers who use their products. I am personally committed to making this integration a success.”

    Pete Stavros, member of KKR and head of the Industrials Investing Team, said, “Since acquiring Capsugel five years ago, we have supported Guido and his management team in repositioning the company from a global leader in hard capsules into a specialty CDMO. Capsugel has grown significantly by investing in innovation, strategic acquisitions, product development and geographic expansion. Now Capsugel is well positioned for the next phase of its growth, and we look forward to its continued success as a part of Lonza.”

    Synergies
    The bulk of the benefits resulting from the transaction will be gained from positive top-line and innovation synergies. The highly synergistic customer base, the expanded addressable market and the improved value proposition for the customer will allow Lonza to further leverage its current product and service offerings. Also the acquisition of Capsugel will allow cross-selling of existing products, combine manufacturing solutions and services and create an integrated value offering that merges Lonza’s ingredients with Capsugel’s dosage forms.

    The primary initial focus of this transaction is to ensure a seamless integration while continuing the strong growth trajectory of the Capsugel business. Lonza believes that the step-by-step integration will preserve the strong innovation culture and lead to a combined top-line synergy potential of around CHF 100 million per annum in the mid- to long-term.

    Lonza expects to achieve operating synergies of CHF ~30 million per annum, which are expected to be fully realized by year three, in the areas of corporate, procurement and IT, as well as various efficiency gains. In addition, tax synergies of CHF ~15 million per annum are expected.

    Lonza anticipates that the transaction will be accretive to its CORE Earnings per Share (EPS) from the first full year post closing onwards and intends to retain its current dividend policy.

    Financing and Approvals
    The $5.5 billion all-cash acquisition of Capsugel will be financed with a combination of debt and equity financing. Lonza has committed debt financing for the full acquisition amount from BofA Merrill Lynch and UBS and plans to raise equity, which is fully underwritten by UBS and BofA Merrill Lynch for an amount up to CHF 3.3 billion.

    Lonza’s Board of Directors is currently authorized to increase the share capital through the issuance of 5,000,000 fully paid-in registered shares. Lonza’s Board intends to seek approval for additional share capital at its upcoming annual general meeting (AGM) in April 2017.

    Lonza expects to retain a leverage profile around ~3x net debt/EBITDA at closing and to maintain its unofficial investment-grade credit profile assigned by a number of Swiss banks. Lonza believes that the strong projected cash flow of the combined company will enable rapid de-leveraging after the acquisition and continue to support all planned growth initiatives.

    The financial package foresees the refinancing of Lonza’s current CHF 700 million revolving credit facility.
    Related Searches
    • World Markets
    • Dietary Supplements
    • Mergers & Acquisitions
    • Delivery & Dosage Technologies
    Related Knowledge Center
    • Delivery & Dosage Technologies
    • World Markets
    • Mergers & Acquisitions
    Suggested For You
    Lonza’s DRcaps® Capsules Positioned to Help Usher in Next Generation Formulations Lonza’s DRcaps® Capsules Positioned to Help Usher in Next Generation Formulations
    Lonza Expands Capsule Manufacturing Capacity Lonza Expands Capsule Manufacturing Capacity
    2020 Branded Ingredient Directory 2020 Branded Ingredient Directory
    Capsugel to Showcase Innovative Dosage Forms and Technologies Capsugel to Showcase Innovative Dosage Forms and Technologies
    Benexia Opens Lipids Research Center in Europe Benexia Opens Lipids Research Center in Europe
    Ashland to Acquire Pharmachem Laboratories for $660 Million Ashland to Acquire Pharmachem Laboratories for $660 Million
    Research on Curcumin, Ginkgo, Chamomile, Pomegranate and More Research on Curcumin, Ginkgo, Chamomile, Pomegranate and More
    Capsugel Puts Fresh Face on In-Stock Capsule Program Capsugel Puts Fresh Face on In-Stock Capsule Program
    Oral Solid Dosage Outsourcing: Trends & Challenges Oral Solid Dosage Outsourcing: Trends & Challenges
    Formulation Strategies for  Aging Consumers Formulation Strategies for Aging Consumers
    Oral Solid Dose and the Psychology of Appearance Oral Solid Dose and the Psychology of Appearance
    Scientists Respond to Coverage of Curcumin Scientists Respond to Coverage of Curcumin
    Formulation Strategies for Aging Consumers Formulation Strategies for Aging Consumers
    Ingredion to Acquire Tic Gums for $400 Million Ingredion to Acquire Tic Gums for $400 Million
    Linnea Hires North American Sales Manager Linnea Hires North American Sales Manager

    Related Breaking News

    • Breaking News | Dietary Supplements | Digestive Health | Healthcare Trends | Immune Function | Medical Nutrition | Proteins, Peptides, Amino Acids | Research | Research News
      NIH Study Identifies Antibacterial Properties in Taurine

      NIH Study Identifies Antibacterial Properties in Taurine

      The amino acid helps the gut “recall” prior infections to kill invading bacteria, the authors of the study said.
      01.15.21

    • Breaking News | Certifications, Approvals & Patents | Contract Manufacturing | Dietary Supplements | Quality & Safety | Testing | World Markets
      NSF Begins New Certification Program

      NSF Begins New Certification Program

      The third-party testing organization will also expand its dietary supplement GMP program to include manufacturers of cosmetics, personal care, and over-the-counter products.
      01.14.21

    • Antioxidants | Breaking News | Dietary Supplements | Herbs & Botanicals | Inflammation | Natural/Organic | Research | Supplier News
      Eriocitrin Shown to Have Metabolic Benefits in Recent Study

      Eriocitrin Shown to Have Metabolic Benefits in Recent Study

      This lemon-sourced flavonone was assessed for benefits to oxidative stress, inflammation, and the metabolism of glucose and lipids in mice.
      01.14.21


    • Breaking News | Consumer Trends | Digestive Health | Fiber & Carbohydrates | Functional Foods & Beverages | Natural/Organic | Nutrition Bars & Snacks | Proteins, Peptides, Amino Acids | Supplier News | World Markets
      EverGrain Introduces Sustainable Barley Ingredients

      EverGrain Introduces Sustainable Barley Ingredients

      Backed by Anheuser-Busch InBev, the company specializes in fiber and protein ingredients sourced from upcycled barley.
      01.14.21

    • Breaking News | Consumer Trends | Functional Foods & Beverages | Healthcare Trends | Industry & Market News | Natural/Organic | World Markets
      Mintel Offers Global Food and Drinks Trends for 2021

      Mintel Offers Global Food and Drinks Trends for 2021

      The company’s market analysis narrowed down three key trends that will define foodservice this year.
      01.12.21

    • Breaking News | Dietary Supplements | Healthcare Trends | Immune Function | Inflammation | Medical Nutrition | Natural/Organic | Omega-3s | Research | Research News
      Preliminary Study Suggests Link Between Omega-3s and Lower COVID-19 Death Rates

      Preliminary Study Suggests Link Between Omega-3s and Lower COVID-19 Death Rates

      While a long stretch from thresholds of significance, the researchers are seeking to further substantiate these initial findings.
      01.12.21


    • Breaking News | Contract Manufacturing | Delivery & Dosage Technologies | Dietary Supplements | Industry & Market News | World Markets
      TA Associates Acquires Significant Stake in OmniActive Health Technologies

      TA Associates Acquires Significant Stake in OmniActive Health Technologies

      The financial terms for the OmniActive acquisition have not been disclosed.
      01.12.21

    • Breaking News | Dietary Supplements | Functional Foods & Beverages | Mood Health & Sleep | Probiotics & Prebiotics | Supplier News | World Markets
      DuPont Introduces HOWARU, a Probiotic Formulated for Stress

      DuPont Introduces HOWARU, a Probiotic Formulated for Stress

      Clinical trials yielded positive results for a new bacterial strain on acute stress tests.
      01.12.21

    • Breaking News | Cognitive Function | Dietary Supplements | Healthcare Trends | Infant & Children's Health | Medical Nutrition | Research | Research News | Sexual & Reproductive Health | Vitamins | Women's Health
      Maternal Vitamin D Concentrations During Gestation Benefits Child Cognitive Development

      Maternal Vitamin D Concentrations During Gestation Benefits Child Cognitive Development

      These findings further substantiate the need for proper nutrition for mothers especially at risk of deficiency.
      01.11.21


    • Breaking News | Dietary Supplements | Healthcare Trends | Immune Function | Medical Nutrition | Research | Research News | Vitamins
      Study Links Vitamin D Deficiency to Incidence and Worsened COVID-19 Outcomes

      Study Links Vitamin D Deficiency to Incidence and Worsened COVID-19 Outcomes

      A recent study in China showed that vitamin D deficiency was among significant risk factors for COVID-19 severity.
      01.11.21

    • Breaking News | Diabetes & Blood Sugar Management | Dietary Supplements | Healthcare Trends | Medical Nutrition | Probiotics & Prebiotics | Research | Research News | Weight Management/Weight Loss
      Researchers Identify Microbes Which Could Benefit Type 2 Diabetes

      Researchers Identify Microbes Which Could Benefit Type 2 Diabetes

      Certain strains are linked to lower BMI, while others appear to beneficially modulate glucose response, lipids, and mitochondrial health in the liver.
      01.08.21

    • Breaking News | Cardiovascular Health | Dietary Supplements | Functional Foods & Beverages | Green Foods | Herbs & Botanicals | Inflammation | Medical Nutrition | Natural/Organic | Research | Research News
      High Flavonoid Intake Linked to Lower Risk of Peripheral Artery Disease Hospitalizations

      High Flavonoid Intake Linked to Lower Risk of Peripheral Artery Disease Hospitalizations

      Flavonoids may attenuate atherosclerosis, the authors of the meta-analysis said.
      01.07.21


    • Breaking News | Cardiovascular Health | Dietary Supplements | Digestive Health | Healthcare Trends | Healthy Aging | Inflammation | Probiotics & Prebiotics | Research | Research News
      Review Highlights Gut Microbiome’s Influence on CVD Risk Factors

      Review Highlights Gut Microbiome’s Influence on CVD Risk Factors

      Several studies suggest that certain gut metabolites could ameliorate atherosclerosis, inflammation, obesity, insulin resistance, and more.
      01.07.21

    • Breaking News | Cardiovascular Health | Dietary Supplements | Healthcare Trends | Medical Nutrition | Natural/Organic | Omega-3s | Research | Research News
      Omega-3s Improve Vascular Stiffness in Abdominal Aortic Aneurysm

      Omega-3s Improve Vascular Stiffness in Abdominal Aortic Aneurysm

      While these preliminary findings are promising, more research is needed to substantiate omega-3s' vasoprotective properties.
      01.06.21

    • Breaking News | Contract Manufacturing | Dietary Supplements | Immune Function | Minerals | Supplier News
      Gadot Reports Stable Zinc Supply for Winter Demand

      Gadot Reports Stable Zinc Supply for Winter Demand

      The company’s supplies of zinc citrate, gluconate, picolinate, and ready-to-use chewables are now at sustainable levels.
      01.06.21

    Trending
    • Nutrition Industry Reacts To 2020-2025 Dietary Guidelines For Americans
    • Preliminary Study Suggests Link Between Omega-3s And Lower COVID-19 Death Rates
    • NOW Raises Additional Concerns About Supplements Available On Amazon
    • High-Protein Meal Replacement Improves Exercise Metabolism Compared To Standard Breakfast
    • Seraphina Therapeutics Formulates Dairy Ingredient For Cellular Health
    Breaking News
    • Brown Fat Associated with Reductions in Chronic Disease Risk
    • NIH Study Identifies Antibacterial Properties in Taurine
    • NSF Begins New Certification Program
    • Eriocitrin Shown to Have Metabolic Benefits in Recent Study
    • EverGrain Introduces Sustainable Barley Ingredients
    View Breaking News >
    CURRENT ISSUE

    December 2020

    • State of the Industry: Positive Market Outlook Despite COVID-19 Turmoil
    • Brain Health: A Mysterious Frontier
    • 2021 International Buyers' Guide
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Brown Fat Associated with Reductions in Chronic Disease Risk
    NIH Study Identifies Antibacterial Properties in Taurine
    NSF Begins New Certification Program
    Coatings World

    Latest Breaking News From Coatings World

    Zeppelin Acquires MTI Mischtechnik
    Ezio Braggio Joins ChemQuest Europe
    IFS Coatings Announce Carbon Offset Program
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Optimize EP Launches CaRM Cardiac Device Data Management Platform
    U.S. TAVR Market Projected to Reach Nearly $5 Billion by 2030
    FDA Clears Canon Medical's Compressed SPEEDER for 3D Exams on 1.5T MR
    Contract Pharma

    Latest Breaking News From Contract Pharma

    KORSCH, MEDELPHARM Partner on R&D Equipment Portfolio
    Frontage Bolsters Clinical Services Capabilities
    Sanofi Unveils EUROAPI as Name of New European API Company
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Neenah to Host Packaging Webinar for Printers
    W.S. Badger is Named a ‘150 Top Impact Company’
    Mana Products, Meiyume and RPG Form The Vertical Beauty Alliance
    Happi

    Latest Breaking News From Happi

    Amyris Named a Top Social & Environmental Impact Company
    L'Oréal Bans Animal Hair in Brushes
    Ashland Launches Antaron ECo Gel
    Ink World

    Latest Breaking News From Ink World

    dar-tech, inc. Becomes U.S. Midwestern Distributor for ZS Interpolymer
    Techkon USA, Konica Minolta Partner
    Alon Bar-Shany Appointed Chairman of Highcon Board
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Exhibitor registration opens for virtual.drupa
    FTA planning in-person Forum & INFOFLEX
    Fortis Solutions Group achieves SGP certification
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Shemesh Adds U.S. Headquarters
    TZMO USA, Special Needs Group Form Partnership
    BAHP Announces 2021 Officers, Board of Directors
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Rapid Recovery Protocol Can Lead to Increased Range of Motion After TKA
    Boston Scientific Releases WaveWriter Alpha Spinal Cord Stimulators in U.S.
    New Chief Clinical Officer on Board at IncludeHealth
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Roadsimple Modernizes Warehouse Ops with Zebra Technologies
    Toppan Announces 2050 Environmental Vision
    SOI Industry Consortium Joins SEMI as Strategic Association Partner

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login